By Benjamin Horney ( May 9, 2016, 3:39 PM EDT) -- California-based oncology biotech Medivation Inc. will explore a sale after having received interest from a number of companies, including Pfizer Inc., Amgen Inc. and Sanofi SA, according to a Monday report from Reuters. According to the report, Medivation, which previously rejected Sanofi's $9.3 billion all-cash buyout bid, has decided that there is enough interest to warrant exploration....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.